Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
Pfizer
PFE
|
+$258M |
| 3 |
Gilead Sciences
GILD
|
+$206M |
| 4 |
Meta Platforms (Facebook)
META
|
+$188M |
| 5 |
Comcast
CMCSA
|
+$179M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$390M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$231M |
| 4 |
Amgen
AMGN
|
+$230M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$154M |
Sector Composition
| 1 | Technology | 14.42% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.5% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Champion Homes, Inc.
SKY
$4.31B
| $367K | ﹤0.01% |
103,100
+8,700
| +9% | +$31K |
|
2827
Stratus Properties
STRS
$161M
| $367K | ﹤0.01% |
18,000
+2,100
| +13% | +$42.8K |
|
|
FCRE
2828
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
| $366K | ﹤0.01% |
162,760
+14,740
| +10% | +$33.1K |
|
|
GLF
2829
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
| $360K | ﹤0.01% |
77,112
-289,200
| -79% | -$1.35M |
|
2830
ImmuCell
ICCC
$55.5M
| $360K | ﹤0.01% |
47,800
+2,600
| +6% | +$19.6K |
|
2831
EVI Industries
EVI
$360M
| $359K | ﹤0.01% |
86,200
+1,400
| +2% | +$5.83K |
|
|
CCXI
2832
DELISTED
ChemoCentryx, Inc.
CCXI
| $359K | ﹤0.01% |
44,300
+19,600
| +79% | +$159K |
|
2833
MediWound
MDWD
$207M
| $356K | ﹤0.01% |
5,957
+2,271
| +62% | +$136K |
|
|
SUMR
2834
DELISTED
Summer Infant, Inc.
SUMR
| $356K | ﹤0.01% |
17,756
-852
| -5% | -$17.1K |
|
2835
Upland Software
UPLD
$70.8M
| $355K | ﹤0.01% |
50,393
+19,994
| +66% | +$141K |
|
|
ADAP
2836
Adaptimmune Therapeutics
ADAP
$13.4M
| $353K | ﹤0.01% |
+29,300
| New | +$353K |
|
|
PACD
2837
DELISTED
Pacific Drilling S A
PACD
| $353K | ﹤0.01% |
42,040
-2,480
| -6% | -$20.8K |
|
|
GZT
2838
DELISTED
Gazit-globe Ltd
GZT
| $352K | ﹤0.01% |
39,200
+2,200
| +6% | +$19.8K |
|
2839
RAVE Restaurant Group
RAVE
$45.6M
| $351K | ﹤0.01% |
54,900
-10,400
| -16% | -$66.5K |
|
2840
First US Bancshares
FUSB
$67.4M
| $350K | ﹤0.01% |
39,200
+5,200
| +15% | +$46.4K |
|
2841
Mind CTI
MNDO
$24.2M
| $350K | ﹤0.01% |
138,375
-17,025
| -11% | -$43.1K |
|
|
WIRE
2842
DELISTED
Encore Wire Corp
WIRE
| $350K | ﹤0.01% |
+9,437
| New | +$350K |
|
|
HSNI
2843
DELISTED
HSN, Inc.
HSNI
| $350K | ﹤0.01% |
6,900
-29,500
| -81% | -$1.5M |
|
2844
MediciNova
MNOV
$61.3M
| $349K | ﹤0.01% |
98,200
-4,900
| -5% | -$17.4K |
|
|
CBIO
2845
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $348K | ﹤0.01% |
609
+131
| +27% | +$74.9K |
|
|
BCRH
2846
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $348K | ﹤0.01% |
20,300
-1,700
| -8% | -$29.1K |
|
|
GFED
2847
DELISTED
Guaranty Federal Bancshares In
GFED
| $346K | ﹤0.01% |
22,700
+2,900
| +15% | +$44.2K |
|
2848
Trio-Tech International
TRT
$22.6M
| $345K | ﹤0.01% |
123,700
+1,100
| +0.9% | +$3.07K |
|
|
TBRA
2849
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $345K | ﹤0.01% |
34,365
-2,700
| -7% | -$27.1K |
|
2850
First Northwest Bancorp
FNWB
$63.1M
| $342K | ﹤0.01% |
+24,200
| New | +$342K |
|